Page 3 - Unicycive Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Shalabh guptaCompany or unicyciveUnicycive therapeutics incChief executive officerThursday april

Piper Sandler Begins Coverage on Unicycive Therapeutics (NASDAQ:UNCY)

Piper Sandler assumed coverage on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report published on Thursday, Marketbeat.com reports. The brokerage issued an overweight rating and a $9.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Noble Financial initiated coverage on Unicycive Therapeutics in […]

United statesPiper sandlerUnicycive therapeutics incGoldman sachs group incGeode capital managementVivo capitalUnicycive therapeuticsFree reportTherapeutics trading downGet free reportSachs groupCapital managementUnicycive therapeutics daily

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

28.03.2024 - – Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose Portion of Clinical Trial Complete – LOS ALTOS, .

Long beachUnited statesShalabh guptaDevelopment rd expensesExchange commissionNational kidney awareness monthDrug administrationCompany or unicyciveUnicycive therapeutics incPnational kidney foundation spring clinical meetingLotus internationalEuropean renal associationChief executive officerNew drug applicationInternational conferenceCritical care nephrology

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu

United statesUnited kingdomSatya medicherlaShalabh guptaExchange commissionEuropean renal associationDrug administrationUnicycive therapeutics incCompany or unicyciveReason researchShire international licensingRenal associatesMoral administrationChief executive officerUrinary phosphorous reductionComparative study

Unicycive Therapeutics (UNCY) Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

Unicycive Therapeutics (UNCY) Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Satya medicherlaShalabh guptaUnicycive therapeutics incIntravenous administrationCompany or unicyciveUnicycive therapeuticsInternational conferenceCritical care nephrologyChief executive officerAcute kidney injuryRat modelDelayed graftVice presidentPreclinical pharmacologyGuru reddy